6-25855230-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_001098486.2(SLC17A3):c.626G>A(p.Gly209Glu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00000745 in 1,610,984 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001098486.2 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC17A3 | NM_001098486.2 | c.626G>A | p.Gly209Glu | missense_variant, splice_region_variant | 6/13 | ENST00000397060.8 | |
LOC124901285 | XR_007059518.1 | n.380-4416C>T | intron_variant, non_coding_transcript_variant | ||||
SLC17A3 | NM_006632.4 | c.392G>A | p.Gly131Glu | missense_variant, splice_region_variant | 5/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC17A3 | ENST00000397060.8 | c.626G>A | p.Gly209Glu | missense_variant, splice_region_variant | 6/13 | 2 | NM_001098486.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152144Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000400 AC: 1AN: 250248Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135228
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1458840Hom.: 0 Cov.: 29 AF XY: 0.00000138 AC XY: 1AN XY: 725840
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152144Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 22, 2022 | The c.392G>A (p.G131E) alteration is located in exon 5 (coding exon 4) of the SLC17A3 gene. This alteration results from a G to A substitution at nucleotide position 392, causing the glycine (G) at amino acid position 131 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at